Search Orphan Drug Designations and Approvals
-
Generic Name: | Hemin | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Panhematin | ||||||||||||||||
Date Designated: | 03/16/1984 | ||||||||||||||||
Orphan Designation: | Amelioration of recurrent attacks of acute intermittent porphyria (AIP) temporarily related to the menstrual cycle in susceptible women and similar symptoms which occur in other patients with AIP, porphyria variegata and hereditary coproporphyria. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Abbott Laboratories Diagnostics Division Abbott Park, Illinois 60064 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | Hemin |
---|---|---|
Trade Name: | Panhematin | |
Marketing Approval Date: | 07/20/1983 | |
Approved Labeled Indication: | ||
Exclusivity End Date: | 07/20/1990 | |
Exclusivity Protected Indication* : | ||
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-